Maxillofacial space infection (MSI) is one of the most common conditions encountered in oral and maxillofacial surgery clinics. Early recognition and proper management of MSI could prevent a life-threatening event. Objectives: To report a series of MSI managed with antibiotics, surgical intervention and exogenous steroids as an adjunct, highlighting functional improvement following steroid administration. Methods: A retrospective cohort study was carried out from December 2013 to September 2016, involving 30 patients (n = 30, 22 males, 8 females) diagnosed with MSI. All patients were initially managed with intravenous empirical antibiotics, analgesics and removal of potential source of infection. A course of 3 doses of IV Dexamethasone 8 mg at an interval of 8 hours was started during the first day of hospital admission. Results: This series reports 30 patients presenting with MSI, who received prompt antibiotics and 3 doses of steroids as in-patients. Significant clinical improvement was noted in the form of amelioration of pain, rapid reduction in edema, and improved trismus, shortening hospital stay to an average of 3.5 days, and omission of surgical intervention in 50% of our cases. No adverse effects or drug reaction was noted. Conclusion: In conclusion, the value of synergistic use of corticosteroids with antibiotics in management of MSI is significant. Despite these promising findings, there is scarce evidence in the literature to fully support the use of corticosteroids in abscess management. The role of corticosteroids in treatment of MSI should be explored further.
Introduction
Maxillofacial space infection (MSI) refers to infection in the potential spaces and butor. A nationwide Emergency Department survey of 450 hospitals in 27 US states in 2007 showed 302,507 visits attributed to facial cellulitis from dental origin [3] . Severe odontogenic infection remains an important public health concern and has become a significant economic burden to public health care facilities. A retrospective study done by Jundt JS et al (2012) on 42 patient records of inpatients treated for odontogenic infections reported a cost of $749,382 averaging $17,842 per person [4] . Another nationwide inpatient sample taken in 2008 from 1056 hospitals in 42 US states shows 4044 hospital discharges with a primary diagnosis of mouth abscess/cellulitis, accounting for $98 million of hospitalization charges at a mean hospital charge of $24,240 per patient [5] .
MSI carries significant risk of morbidities and mortality. Late, incorrect or non-treatment could lead to life-threatening complications, such as airway compromise [ [15] . In the pre-antibiotic era, odontogenic infections were associated with a mortality rate of 10% -40% [27] . The advent and implementation of modern antibiotics have significantly reduced mortality rates associated with odontogenic infections [4] . The basic diagnostic protocol included anamnesis, examination of oral cavity/ infection site and the use of imaging techniques (intraoral periapical radiographs, occlusal radiographs, or orthopantomogram) to achieve the diagnosis.
Materials and Methods
Laboratory tests were also requested: full blood count for all cases, and other tests according to case based needs. 
Results
A total of 30 patients were reviewed based on the inclusion criteria, 22 of which male and 8 female. Only 2 pediatric patients, ages 6 and 7 years old, were treated. Open Journal of Stomatology
The mean age of the group was 32.1 years [ Table 1 ]. Mandible (67%) was more frequently involved than maxilla (33%) [ Figure 1 ]. Involvement of the left side (50%) was slightly more than right (40%), whereas 1% of infections were recorded as bilateral. 30% of patients presented with involvement of more than one anatomical space [ Table 1 ].
Regarding the etiology of MSI, most frequent cause was dental caries (17 patients, representing 56% of recorded cases), followed by pericoronitis (6 patients, 20%), cysts, periodontitis and soft tissue injury (2 cases each, 6.6% each) and post extraction (1 patient, 3%) [ Figure 2 ].
Of the total study sample, incision and drainage under local anesthesia was done for 50% of the patients. The average length of stay in the hospital was 3.46
days. In terms of improvement in trismus (0 -24 hours post steroid administration), a majority (33%) of patients showed 0.5 cm increase in mouth opening, maximum improvement is of 2 cm (6.6%). However, 13% of patients had reducing mouth opening and 20% showed no significant change [ Figure 3 ]. 86%
of patients showed a 2 -4 cm reduction in swelling size (0 -24 hours post steroid administration), whereas 6.6% showed improvement of more than 4cm and less than 2 cm respectively [ Figure 4 ].
Discussion
Traditionally, treatment of MSI involves prompt initiation of antibiotic therapy, with or without surgical intervention. Despite this, patients sometimes fail to improve, or even worse, deteriorate further. This is particularly observed in cases Open Journal of Stomatology [36] . However, the role of corticosteroids in management of MSI has not been extensively studied [29] [37] .
The ideal evidence to justify the conclusion that steroids improve the outcome in maxillofacial space infection management would be a study, which shows a clear comparison between 2 groups (group which receives intravenous antibiotics along with adjunctive steroids versus group which receives intravenous antibiotics without adjunctive steroids). However, as most retrospective studies, data of patients are often not complete. The comparison between steroids versus non-steroids group would be difficult and biased (Steroids are not given to diabetic patients in our centre, and comparing the 2 groups would further skew the results as most diabetic patients have poorer recovery). On the other hand, steroids are given as a first line adjunctive treatment in low-risk patients in this centre, hence the confounding factors of surgical intervention and antibiotics could not be negated.
Conclusion
In conclusion, the value of synergistic use of corticosteroids with antibiotics in management of MSI is significant. Despite these promising findings, there is scarce evidence in the literature to fully support the use of corticosteroids in MSI management. The role of corticosteroids in treatment of MSI should be explored further.
